Susquehanna International Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,984
Closed -$589K 13267
2020
Q4
$589K Sell
4,984
-20,811
-81% -$2.42M ﹤0.01% 7929
2020
Q3
$2.87M Sell
25,795
-1,375
-5% -$148K ﹤0.01% 3948
2020
Q2
$2.78M Buy
27,170
+1,454
+6% +$156K ﹤0.01% 3929
2020
Q1
$2.78M Sell
25,716
-6,259
-20% -$719K ﹤0.01% 3419
2019
Q4
$3.72M Sell
31,975
-252,817
-89% -$29.3M ﹤0.01% 3386
2019
Q3
$32.6M Buy
284,792
+173,130
+155% +$17.2M 0.01% 989
2019
Q2
$10.6M Buy
111,662
+40,840
+58% +$3.85M ﹤0.01% 1815
2019
Q1
$6.46M Buy
70,822
+39,957
+129% +$3.27M ﹤0.01% 2170
2018
Q4
$2.34M Sell
30,865
-44,655
-59% -$3.29M ﹤0.01% 3295
2018
Q3
$6.04M Buy
75,520
+23,218
+44% +$2.16M ﹤0.01% 2455
2018
Q2
$5.2M Buy
52,302
+33,449
+177% +$2.89M ﹤0.01% 2660
2018
Q1
$1.53M Sell
18,853
-16,889
-47% -$1.37M ﹤0.01% 4423
2017
Q4
$2.81M Buy
+35,742
New +$2.97M ﹤0.01% 3341
2017
Q1
Sell
-15,332
Closed -$1.64M 10719
2016
Q4
$1.65M Sell
15,332
-91,288
-86% -$10.7M ﹤0.01% 4482
2016
Q3
$13.3M Buy
106,620
+26,465
+33% +$3.12M 0.01% 1308
2016
Q2
$8.52M Buy
80,155
+58,328
+267% +$6.77M ﹤0.01% 1586
2016
Q1
$2.5M Buy
21,827
+7,007
+47% +$822K ﹤0.01% 3355
2015
Q4
$2.11M Sell
14,820
-24,100
-62% -$2.78M ﹤0.01% 3926
2015
Q3
$3.5M Sell
38,920
-12,299
-24% -$1.3M ﹤0.01% 3234
2015
Q2
$5.9M Buy
51,219
+34,566
+208% +$3.63M ﹤0.01% 2667
2015
Q1
$1.59M Buy
16,653
+6,145
+58% +$460K ﹤0.01% 4773
2014
Q4
$706K Buy
+10,508
New +$651K ﹤0.01% 6545
2014
Q3
Sell
-10,858
Closed -$534K 10320
2014
Q2
$483K Buy
+10,858
New +$444K ﹤0.01% 7548

Other funds holding CBPO

Susquehanna International Group's CBPO Position: Q1 2021 in Review

Susquehanna International Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 4,984 shares — an estimated $589K sold.

Susquehanna International Group first reported a position in CBPO in Q2 2014 and held it in 23 quarters. The position peaked at $32.6M in Q3 2019. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Susquehanna International Group reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Susquehanna International Group sold 4,984 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $589K.
  • Susquehanna International Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 23 quarters.
  • Susquehanna International Group's China Biologic Products Holdings, Inc. position peaked at $32.6M in Q3 2019.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.